发明申请
US20140128424A1 Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
有权
羟基取代的咪唑并[1,2-a] - 吡啶甲酰胺及其用途
- 专利标题: Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
- 专利标题(中): 羟基取代的咪唑并[1,2-a] - 吡啶甲酰胺及其用途
-
申请号: US13789208申请日: 2013-03-07
-
公开(公告)号: US20140128424A1公开(公告)日: 2014-05-08
- 发明人: Alexandros VAKALOPOULOS , Ingo HARTUNG , Markus FOLLMANN , Rolf JAUTELAT , Alexander STRAUB , Jorma HASSFELD , Niels LINDNER , Dirk SCHNEIDER , Frank WUNDER , Johannes-Peter STASCH , Gorden REDLICH , Volkhart Min-Jian LI , Eva-Maria BECKER , Andreas KNORR
- 申请人: BAYER PHARMA AKTIENGESELLSCHAFT
- 申请人地址: DE Berlin
- 专利权人: BAYER PHARMA AKTIENGESELLSCHAFT
- 当前专利权人: BAYER PHARMA AKTIENGESELLSCHAFT
- 当前专利权人地址: DE Berlin
- 优先权: EP12191200.0 20121105
- 主分类号: A61K31/437
- IPC分类号: A61K31/437 ; A61K45/06 ; C07D471/04
摘要:
The present application relates to novel substituted imidazo[1,2-a]pyridine-3-carboxamides, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.
公开/授权文献
信息查询
IPC分类: